Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 1024 | 31 | 0.7923 | 0.6896 | 0.0303 | 0.0319 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 1078 | 44 | 0.7919 | 0.7554 | 0.0408 | 0.0454 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 3246 | 205 | 0.7908 | 0.7665 | 0.0632 | 0.0659 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 2 | 854 | 49 | 0.7905 | 0.7915 | 0.0574 | 0.0491 |
WM-115 | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 3266 | 231 | 0.7892 | 0.7584 | 0.0707 | 0.0699 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.316 | 0.000 | uM | 72 | hr | 2 | 2781 | 210 | 0.7888 | 0.7819 | 0.0755 | 0.0740 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 2523 | 106 | 0.7883 | 0.7091 | 0.0420 | 0.0504 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 3 | 2580 | 113 | 0.7822 | 0.8880 | 0.0438 | 0.0519 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 1 | 2852 | 143 | 0.7815 | 0.9528 | 0.0501 | 0.0436 |
WM-115 | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 3 | 3116 | 226 | 0.7812 | 0.7324 | 0.0725 | 0.0776 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 1.000 | uM | 72 | hr | 1 | 811 | 41 | 0.7796 | 0.6166 | 0.0506 | 0.0527 |
MZ7-mel | Vemurafenib | Defactinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 3728 | 187 | 0.7781 | 0.7316 | 0.0502 | 0.0510 |
MMAC-SF | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 1139 | 164 | 0.7779 | 0.7237 | 0.1440 | 0.1418 |
WM-115 | Vemurafenib | I-BET151 | 0.316 | 0.000 | uM | 72 | hr | 2 | 2905 | 193 | 0.7773 | 0.7662 | 0.0664 | 0.0650 |
MZ7-mel | Vemurafenib | Defactinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 3707 | 187 | 0.7735 | 0.7316 | 0.0504 | 0.0510 |
WM-115 | Vemurafenib | I-BET | 0.316 | 0.000 | uM | 72 | hr | 2 | 2870 | 175 | 0.7731 | 0.7817 | 0.0610 | 0.0634 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 16963 | 834 | 0.7730 | 0.8197 | 0.0492 | 0.0506 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 1 | 792 | 31 | 0.7705 | 0.6021 | 0.0391 | 0.0426 |
WM-115 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 2 | 3291 | 245 | 0.7704 | 0.8272 | 0.0744 | 0.0678 |
WM-115 | Vemurafenib | I-BET | 0.316 | 0.000 | uM | 72 | hr | 1 | 2875 | 195 | 0.7688 | 0.7817 | 0.0678 | 0.0634 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 1 | 2574 | 151 | 0.7682 | 0.5584 | 0.0587 | 0.0586 |
COLO 858 | Vemurafenib | I-BET | 0.000 | 1.000 | uM | 72 | hr | 1 | 2930 | 418 | 0.7680 | 0.7140 | 0.1427 | 0.1213 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.316 | 3.160 | uM | 72 | hr | 1 | 860 | 78 | 0.7679 | 0.6000 | 0.0907 | 0.1021 |
WM-115 | Vemurafenib | I-BET151 | 0.316 | 0.000 | uM | 72 | hr | 1 | 2860 | 182 | 0.7676 | 0.7662 | 0.0636 | 0.0650 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 3 | 2777 | 121 | 0.7662 | 0.6853 | 0.0436 | 0.0479 |